Anders Mikael Sjödin

Anders Mikael Sjödin

Professor emeritus, Professor, emeritus


  1. 2016
  2. Published

    Iron and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 19 Jul 2016, In: E F S A Journal. 14, 7, 8 p., 4548.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  3. Published
  4. Published

    Polydextrose and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 25 May 2016, In: E F S A Journal. 14, 5, 12 p., 4480.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  5. Published

    DHA and improvement of memory function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2 May 2016, In: E F S A Journal. 14, 5, 19 p., 4455.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  6. Published

    Creatine in combination with resistance training and improvement in muscle strength: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 23 Feb 2016, In: E F S A Journal. 14, 2, 17 p., 4400.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  7. Published

    Fabenol® Max, a standardised aqueous extract from Phaseolus vulgaris L., and ‘reduces the absorption of carbohydrates’: evaluation of a health claim pursuant toArticle 13(5) of Regulation (EC) No 1924/2006: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 23 Feb 2016, In: E F S A Journal. 14, 2, 8 p., 4401.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  8. Published

    General scientific guidance for stakeholders on health claim applications: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 18 Jan 2016, In: E F S A Journal. 14, 1, 38 p., 4367.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  9. Published

    Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms: (Scientific Oplinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 18 Jan 2016, In: E F S A Journal. 14, 1, 23 p., 4369.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  10. Published

    Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 12 Jan 2016, In: E F S A Journal. 14, 1, 30 p., 4368.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  11. Published

    Safety of UV-treated milk as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 11 Jan 2016, In: E F S A Journal. 14, 1, 14 p., 4370.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

ID: 4232923